Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lenskart SolutionsBOM:544600 +0.93%11 EBITDA Margin % is 23.26% as of Mar. 2026, which is 22% above its 10-year median of 19.06. GuruFocus rates BOM:544600 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Lenskart Solutions ranks better than 78.4% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lenskart Solutions's EBITDA for the
three
months ended in Mar. 2026 was ₹5,852 Mil. Lenskart Solutions's Revenue for the
three
months ended in Mar. 2026 was ₹25,157 Mil. Therefore, Lenskart Solutions's EBITDA margin for the quarter that ended in Mar. 2026 was 23.26%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Lenskart Solutions EBITDA Margin % Related Terms
Lenskart Solutions EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Lenskart Solutions's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544600 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Lenskart Solutions's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lenskart Solutions EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lenskart Solutions's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Lenskart Solutions's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lenskart Solutions (BOM:544600) has a EBITDA Margin % of 23.26% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lenskart Solutions and its competitors. This is 22% above median its historical median of 19.06. Over the past decade, Lenskart Solutions' EBITDA Margin % has ranged from 11.78 to 21.73. According to the industry distribution chart, Lenskart Solutions ranks #176 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 21.6%.
Is Lenskart Solutions' EBITDA Margin % too high?
Lenskart Solutions' current EBITDA Margin % of 23.26% is 22% above median its 10-year median of 19.06. Over the past 10 years, this metric has ranged from a low of 11.78 to a high of 21.73. The Medical Devices & Instruments industry median EBITDA Margin % is 7.52. Lenskart Solutions' value of 23.26% is 209.3% above this industry median. Based on the distribution chart, Lenskart Solutions ranks #176 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lenskart Solutions has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Lenskart Solutions' EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Lenskart Solutions ranks #176 out of 815 companies for EBITDA Margin %. This places Lenskart Solutions in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.52. Lenskart Solutions' value of 23.26% is 209.3% above this benchmark. Historically, Lenskart Solutions' own EBITDA Margin % has ranged from 11.78 to 21.73 over the past decade. While the company's 10-year median is 19.06 vs. the industry median of 7.52, Lenskart Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.52, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lenskart Solutions's current EBITDA Margin % of 23.26% is 209.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lenskart Solutions and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lenskart Solutions's current EBITDA Margin % is 23.26%, which is 22% above median its own 10-year median of 19.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lenskart Solutions stock overvalued right now?
Lenskart Solutions (BOM:544600) has a current EBITDA Margin % of 23.26%. The current EBITDA Margin % is 23.26%, which is 22% above median its 10-year median of 19.06 and 209.3% above the Medical Devices & Instruments industry median of 7.52. Lenskart Solutions' overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Lenskart Solutions (BOM:544600), the current EBITDA Margin % is 23.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lenskart Solutions Ltd is a technology-driven eyewear company, with a belief that clear vision is fundamental to personal development and well-being. It sells a range of eyewear products including prescription eyeglasses, sunglasses, and other products such as contact lenses and eyewear accessories.
11GF Score
Get the complete analysis for BOM:544600
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544600 has been successfully added to your 
